Catalyst Crew Technologies Corp., a digital health and artificial intelligence technology company, has assigned three Venezuelan patents to its wholly-owned Venezuelan operating subsidiary, Inversiones Long 33, C.A. The intellectual property, previously held by CEO Dr. Kevin Rodan Levy, includes proprietary technologies called CardioAI, PulmoAI, and NeuroAI, which are designed for healthcare analytics, predictive modeling, and clinical decision-support applications. This assignment represents a strategic step in aligning the company's intellectual property with its operating structure, positioning the subsidiary as the primary development and commercialization vehicle for its technology platform in the region.
According to the company, consolidating intellectual property at the operating level enhances strategic flexibility, supports regulatory alignment, and may facilitate future partnerships, licensing opportunities, and regional expansion initiatives. Dr. Kevin Rodan Levy stated that aligning intellectual property within the operating structure is important as the company continues building its platform. Establishing a clear foundation around core technologies allows the company to move forward with development, partnerships, and, where appropriate, broader intellectual property protection strategies across additional markets.
In addition to the Venezuelan assignment, the company intends to pursue expanded intellectual property protection for its technologies in additional jurisdictions worldwide as practical, supporting long-term platform development and potential international deployment. The company continues to advance its digital health and artificial intelligence platform with a focus on scalable healthcare solutions including telehealth infrastructure, remote patient monitoring, and advanced healthcare analytics designed to improve access, efficiency, and care coordination. For more information about the company's developments, investors can review filings with the U.S. Securities and Exchange Commission at https://www.sec.gov. Additional company information is available through its corporate website at https://catalystcrewai.com.
